ZA200601599B - Pharmaceutical formulation comprising a pyrimidine-A-one derivative coated with an enteric polymer - Google Patents

Pharmaceutical formulation comprising a pyrimidine-A-one derivative coated with an enteric polymer

Info

Publication number
ZA200601599B
ZA200601599B ZA200601599A ZA200601599A ZA200601599B ZA 200601599 B ZA200601599 B ZA 200601599B ZA 200601599 A ZA200601599 A ZA 200601599A ZA 200601599 A ZA200601599 A ZA 200601599A ZA 200601599 B ZA200601599 B ZA 200601599B
Authority
ZA
South Africa
Prior art keywords
pyrimidine
pharmaceutical formulation
enteric polymer
derivative coated
derivative
Prior art date
Application number
ZA200601599A
Other languages
English (en)
Inventor
Schie Dirk Marinus Johannes Van
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA200601599B publication Critical patent/ZA200601599B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA200601599A 2003-09-02 2006-02-23 Pharmaceutical formulation comprising a pyrimidine-A-one derivative coated with an enteric polymer ZA200601599B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0320522.6A GB0320522D0 (en) 2003-09-02 2003-09-02 Formulation

Publications (1)

Publication Number Publication Date
ZA200601599B true ZA200601599B (en) 2007-05-30

Family

ID=28686767

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200601599A ZA200601599B (en) 2003-09-02 2006-02-23 Pharmaceutical formulation comprising a pyrimidine-A-one derivative coated with an enteric polymer

Country Status (30)

Country Link
US (2) US20060287346A1 (da)
EP (1) EP1663243B1 (da)
JP (1) JP4892346B2 (da)
KR (1) KR101115984B1 (da)
CN (2) CN1874778B (da)
AR (1) AR045547A1 (da)
AT (1) ATE422889T1 (da)
AU (1) AU2004268376B2 (da)
BR (1) BRPI0414038A (da)
CA (1) CA2537178C (da)
CY (1) CY1108953T1 (da)
DE (1) DE602004019547D1 (da)
DK (1) DK1663243T3 (da)
ES (1) ES2319124T3 (da)
GB (1) GB0320522D0 (da)
HR (1) HRP20090147T3 (da)
IL (1) IL173910A (da)
IS (1) IS2677B (da)
MA (1) MA28033A1 (da)
MX (1) MXPA06002436A (da)
MY (1) MY139165A (da)
NO (1) NO333744B1 (da)
NZ (1) NZ545453A (da)
PL (1) PL1663243T3 (da)
PT (1) PT1663243E (da)
RU (1) RU2359660C2 (da)
SI (1) SI1663243T1 (da)
TW (1) TWI343257B (da)
WO (1) WO2005021002A1 (da)
ZA (1) ZA200601599B (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0320522D0 (en) * 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation
AU2008251467B2 (en) 2007-05-11 2014-07-31 The Trustees Of The University Of Pennsylvania Methods of treatment of skin ulcers
CN101986785A (zh) 2007-05-11 2011-03-16 托马斯杰弗逊大学 治疗和预防神经退行性疾病和紊乱的方法
JP6222924B2 (ja) 2009-04-24 2017-11-01 イシューティカ ピーティーワイ リミテッド ジクロフェナクの新規製剤
EP2651403B1 (en) 2010-12-17 2020-12-02 Glaxo Group Limited Use of lp-pla2 inhibitors in the treatment and prevention of eye diseases
WO2013082275A1 (en) 2011-11-30 2013-06-06 Trustees Of Boston College Inhibitors of phosphodiesterases 11 (pde11) and methods of use to elevate cortisol production
US9526734B2 (en) 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
CN106536521B (zh) 2014-07-22 2018-08-03 葛兰素史密斯克莱知识产权发展有限公司 化合物

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3619570C1 (en) 1986-06-11 1987-10-29 Kneipp Werke Kneipp Mittel Zen Coated garlic tablet
US4971805A (en) 1987-12-23 1990-11-20 Teysan Pharmaceuticals Co., Ltd. Slow-releasing granules and long acting mixed granules comprising the same
IT1227899B (it) * 1988-12-23 1991-05-14 Poli Ind Chimica Spa Rivestimento totale o parziale di principi attivi farmaceutici e relative composizioni
TW209174B (da) 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
JPH07223970A (ja) 1994-02-10 1995-08-22 Tanabe Seiyaku Co Ltd 消化管内適所放出製剤
JP2917799B2 (ja) 1994-03-11 1999-07-12 田辺製薬株式会社 消化管内適所放出型製剤
SG80553A1 (en) 1995-07-20 2001-05-22 Tanabe Seiyaku Co Pharmaceutical preparation in form of coated capsule releasable at lower part of digestive tract
JP3185206B2 (ja) * 1995-07-20 2001-07-09 田辺製薬株式会社 消化管下部放出型被覆カプセル製剤
JP2000514406A (ja) * 1996-06-06 2000-10-31 ビフォーダン アクティーゼルスカブ アルギン酸から成る経口投与製剤用腸溶性被膜
CA2262595C (en) 1996-08-15 2005-10-18 Losan Pharma Gmbh Easy to swallow oral medicament composition
US6296876B1 (en) * 1997-10-06 2001-10-02 Isa Odidi Pharmaceutical formulations for acid labile substances
DK2263660T3 (da) * 1998-05-18 2018-01-02 Takeda Pharmaceuticals Co Oralt desintegrerende tabletter.
HK1040910B (en) * 1998-11-12 2009-06-26 Smithkline Beecham Plc Pharmaceutical composition for modified release of an insulin sensitiser and metformin
US6268385B1 (en) 1999-08-26 2001-07-31 Robert R. Whittle Dry blend pharmaceutical formulations
EP1686119B1 (en) * 2000-02-16 2009-07-29 Smithkline Beecham Plc Pyrimidine-5-one derivatives as LDL-PLA2 inhibitors
AUPQ672800A0 (en) * 2000-04-06 2000-05-04 Natraherbal Pty Ltd Garlic supplement for deodoriser
ATE273695T1 (de) * 2000-06-28 2004-09-15 Smithkline Beecham Plc Nassvermahlung
PT1405621E (pt) 2001-06-20 2011-05-31 Takeda Pharmaceutical Processo de prepara??o de comprimidos
JP5138856B2 (ja) * 2001-06-20 2013-02-06 武田薬品工業株式会社 錠剤の製造方法
RU2203671C1 (ru) * 2002-03-25 2003-05-10 Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" Противовирусный лекарственный препарат для перорального применения
GB0320522D0 (en) * 2003-09-02 2003-10-01 Glaxo Group Ltd Formulation

Also Published As

Publication number Publication date
MXPA06002436A (es) 2006-06-20
JP4892346B2 (ja) 2012-03-07
CA2537178C (en) 2013-03-19
NO333744B1 (no) 2013-09-09
ATE422889T1 (de) 2009-03-15
KR101115984B1 (ko) 2012-03-13
WO2005021002A1 (en) 2005-03-10
MA28033A1 (fr) 2006-07-03
JP2007504195A (ja) 2007-03-01
US20060287346A1 (en) 2006-12-21
CN1874778B (zh) 2011-06-22
CY1108953T1 (el) 2014-07-02
DE602004019547D1 (de) 2009-04-02
SI1663243T1 (sl) 2009-06-30
AU2004268376B2 (en) 2010-04-22
US8772303B2 (en) 2014-07-08
EP1663243B1 (en) 2009-02-18
NO20061514L (no) 2006-04-03
EP1663243A1 (en) 2006-06-07
RU2359660C2 (ru) 2009-06-27
HK1091734A1 (en) 2007-01-26
DK1663243T3 (da) 2009-05-04
AU2004268376A1 (en) 2005-03-10
AR045547A1 (es) 2005-11-02
CN102204891A (zh) 2011-10-05
TW200517113A (en) 2005-06-01
PT1663243E (pt) 2009-04-27
CN102204891B (zh) 2013-08-21
PL1663243T3 (pl) 2009-07-31
IL173910A0 (en) 2006-07-05
NZ545453A (en) 2009-12-24
RU2006110546A (ru) 2006-08-10
ES2319124T3 (es) 2009-05-04
HRP20090147T3 (hr) 2009-04-30
KR20060118422A (ko) 2006-11-23
US20090306113A1 (en) 2009-12-10
IS8366A (is) 2006-03-20
CN1874778A (zh) 2006-12-06
BRPI0414038A (pt) 2006-10-24
CA2537178A1 (en) 2005-03-10
IL173910A (en) 2010-11-30
MY139165A (en) 2009-08-28
GB0320522D0 (en) 2003-10-01
IS2677B (is) 2010-09-15
TWI343257B (en) 2011-06-11

Similar Documents

Publication Publication Date Title
IL221199A (en) A fragrance-containing drug
AU2002343622A1 (en) Polymer coatings for drug delivery devices
AU2003901813A0 (en) Pharmaceutical derivatives
IL173053A0 (en) Pharmaceutical compositions having a swellable coating
GB0316206D0 (en) Pharmaceutical formulation
IL173910A (en) Pharmaceutical formulation comprising a pyrimidine-a-one derivative coated with an enteric polymer
IL149377A0 (en) Pharmaceutical formulation comprising melatonin
DK2918286T3 (da) En farmaceutisk formulering
EP1549291A4 (en) INJECTION FORMULATION
AU2003272053A1 (en) Polymer microneedles
AU2003253456A1 (en) A surface-light source-condensing stand
AU2003237928A1 (en) Carboxamides derivatives
GB0522473D0 (en) A pharmaceutical formulation
GB0310881D0 (en) Pharmaceutical formulation
AU2003238900A1 (en) Pharmaceutical formulation
AU2003905750A0 (en) A drug delivery device
AU2003904627A0 (en) Pharmaceutical Formulation
GB0302435D0 (en) Pharmaceutical formulation
AU2003266376A1 (en) Polypeptides and polynucleotides for use as a medicament
AU2004902190A0 (en) Pharmaceutical Formulation
GB0303724D0 (en) Polymer coating
AU2003906961A0 (en) A joiner
AU2002950788A0 (en) Pharmaceutical formulation
GB0225041D0 (en) Pharmaceutical formulation
GB0203801D0 (en) Polymer coating